Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care. [Phase 2]

View source ↗

Summary

The trial is investigating the efficacy and safety of oral midazolam to facilitate care delivery in elderly patients with neurocognitive disorders who refuse ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midazolam (Midazolam)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Neurocognitive Disorders | Phase 2 | Status: RECRUITING